QuantiFERON-TB Gold Plus CLIA vs. T-SPOT.TB in patients with immunosuppressive conditions - Vienna 2024

Tuberculosis prevention

Chair(s): Akhlesh Rajpoot, Ay?eg?l Fusun ?ner Ey?bo?lu

Session type: Poster session

QuantiFERON-TB Gold Plus CLIA vs. T-SPOT.TB in patients with immunosuppressive conditions

Miguel Arias Guillen

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

One-Month Rifapentine plus Isoniazid (1HP) is a safe regimen for LTBI treatment in non-HIV population: A randomized controlled trial

Jann-yuan Wang

Poster

Abstract

Latent tuberculosis and immune-mediated inflammatory diseases: the performance of TST and IGRA

Ana Paula Santos

Poster

Abstract

A review of latent TB infection screening practices in south-west England: A need for consensus

Danielle Bruchez

Poster

Abstract

Rifapentine + isoniazid for latent tuberculosis infection in Brazil: a retrospective cohort study

Ana Paula Santos

Poster

Abstract

Integrated approach to lung health screening through mobile X-ray technology: experience from Odeska Oblast, Ukraine

Liana Kovtunovych

Poster

Abstract

Active TB related to IGRA conversion in a dynamic cohort of patients with Inflammatory Bowel Disease receiving biological therapy, with up to 14 years of follow-up.

Miguel Arias Guillen

Poster

Abstract

Risk of tuberculosis and uptake rates of latent tuberculosis infection(LTBI) screening among clinical risk groups in South Korea: A nationwide population-based cohort study

Yun Seok Kim

Poster

Abstract

Contact investigation after exposure to TB in healthcare workers

Aikaterini Manika

Poster

Abstract

QuantiFERON-TB Gold Plus CLIA vs. T-SPOT.TB in patients with immunosuppressive conditions

Miguel Arias Guillen

Poster

Abstract

Pyridoxine levels in healthy patients receiving isoniazid for latent tuberculosis infection

Sivan-haia Perl

Poster

Abstract

Comparative analysis of LTBI treatment tolerance across age groups: a retrospective monocentric observational study

Irene Sini

Poster

Abstract

The impact of the COVID-19 pandemic on the latent tuberculosis service in Southampton

Mila Bilsland

Poster

Abstract

An analysis of the effectiveness of the latent tuberculosis service in Southampton - the reasons for treatment non-adherence

Mila Bilsland

Poster

Abstract

Characteristics of patients with borderline T-SPOT.TB test and retest results

Andreas Fl?e

Poster

Abstract

LTBI screening in tuberculosis low-incidence country can a negative IGRA cancel a positive TST result?

Sivan-haia Perl

Poster

Abstract

Latent tuberculosis and biotherapy in chronic inflammatory diseases: value of the QuantiFERON TB Gold Plus test in diagnosis

Fatima Zahra Souid

Poster

Abstract

The prevalence and predictors of latent TB infection (LTBI) of COPD patients in Taiwan

Hung-ling Huang

Poster

Abstract

Cost of Tuberculosis (TB) screening and contact tracing an Eastern European immigrant population seasonally employed at an agricultural farm in the United Kingdom

Harmesh Moudgil

Poster

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}